AAV vectors for gene delivery to the lung

Details AAV vectors for gene delivery to the lung AAV vectors for gene delivery to the lung

2005-06-02

2008-09-23

Crouch, Deborah (Department: 1632)

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Genetically modified micro-organism, cell, or virus

C424S093100, C435S320100

Reexamination Certificate

active

07427396

ABSTRACT:
Methods of making and using recombinant AAV vectors and virions for gene delivery to the lung are described. The recombinant AAV virions are derived from caprine AAV and bovine AAV, both of which display tropism for lung tissue.

REFERENCES:
patent: 5139941 (1992-08-01), Muzyczka et al.
patent: 6001650 (1999-12-01), Colosi
patent: 6004797 (1999-12-01), Colosi
patent: 6156303 (2000-12-01), Russell et al.
patent: 6376237 (2002-04-01), Colosi
patent: WO2005/056807 (2005-06-01), None
Arbetman, AE et al J Virol 79(24):15238-15245, 2005.
Driskell, RA and JF Engelhardt. An Rev Physiol 65:585-612, 2003.
Grimm, D. Methods 28:146-157, 2002.
Hemadri, D. et al Epidemiol Infect 125(3):abstract and sequences, 2000.
(Caprine or goat) AAV entrez sequence search. 3 pages.
(Bovine or cow or cattle) VP1 entrez sequence search. 5 pages.
Flotte, TR Current Gene Therapy 5:361-366, 2005.
Auricchio et al., “Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins,” (2002) J Clin Invest 110(4):499-504.
Bals et al., “Transduction of well-differentiated airway epithelium by recombinant adeno-associated virus is limited by vector entry,” (1999) J Virol 73(7):6085-8.
Beck et al., “Repeated delivery of adeno-associated virus vectors to the rabbit airway,” (1999) J Virol 73(11):9446-55.
Chiorini et al., “Cloning and characterization of adeno-associated virus type 5,” J.Virol 1999; 73(2):1309-1319.
Fischer et al., “Successful transgene expression with serial doses of aerosolized rAAV2 vectors in rhesus macaques,” (2003) Mol Ther 8(6):918-26.
Flotte et al., “Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study,” (2003) Hum Gene Ther 14(11):1079-88.
Gao et al., “Novel adeno-associated virsues from rhesus monkeys as vectors for human gene therapy,” (2002) Proc. Natl. Acad. Sci. USA 99(18):11854-9.
Goncz et al., “Expression of DeltaF508 CFTR in normal mouse lung after site-specific modification of CFTR sequences by SFHR,” (2001) Gene Ther 8(12):961-5.
Grimm et al., “Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy,” (2003) Blood 102(7):2412-9.
Halbert et al., “Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes,” (2000) J Virol 74(3):1524-32.
Halbert et al., “Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to . . . ,” (2001) J Virol 75(14):6615-24.
Heid et al., “Real time quantitative PCR,” (1996) Genome Res 6(10):986-94.
Hofland et al., “In vivo gene transfer by intravenous administration of stable cationic lipid/DNA complex,” (1997) Pharm Res 14(6):742-9.
Matsushita et al., “Adeno-associated virus vectors can be efficiently produced without helper virus,” (1998) Gene Ther 5)7):938-45.
Miao et al., “Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro,” (2000) Mol. Ther. 1(6):522-532.
Miao et al., “High-level factor VIII gene expression in vivo achieved by nonviral liver-specific gene therapy vectors,” (2003) Hum Gene Ther 14(14):1297-305.
Rutledge et al., “Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2,” (1998) J. Virol. 72(1):309-319.
Schmidt et al., “Cloning and characterization of a bovine adeno-associated virus,” (2004) J. Virol. 78(12):6509-16.
Sommer et al., “Quantification of adeno-associated virus particles and empty capsids by optical density measurement,” (2003) Mol Ther 7(1):122-8.
Walter et al., “Successful expression of human factor IX following repeat administration of adenoviral vector in mice,” (1996) Proc Natl Acad Sci U S A 93(7):3056-61.
Wilson, J.M., “Gene therapy for cystic fibrosis: challenges and future directions,” (1995) J Clin Invest 96(6):2547-54.
De, et al., Intrapleural Administration of a Serotype 5 Adeno-Associated Virus Coding for a 1-Antitrypsin Mediates Persistent, High Lung and Serum Levels of a 1-Antitrypsin,Mol Ther10(6):1003-1010 (2004).

Affiliated with

Also associated with

Rating

AAV vectors for gene delivery to the lung does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with AAV vectors for gene delivery to the lung, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and AAV vectors for gene delivery to the lung will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3990637